We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.2B
AUM Growth
+$1.49B
Cap. Flow
-$841M
Cap. Flow %
-4.62%
Top 10 Hldgs %
18.93%
Holding
2,614
New
37
Increased
460
Reduced
567
Closed
1,419

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$87.4M
2
LRCX icon
Lam Research
LRCX
+$69.8M
3
V icon
Visa
V
+$62.2M
4
FISV
Fiserv Inc
FISV
+$55.7M
5
XLNX
Xilinx Inc
XLNX
+$41.2M

Sector Composition

Rank Sector Weight
1 Technology 23.75%
2 Healthcare 13.19%
3 Financials 11.7%
4 Consumer Discretionary 8.69%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
76
Illinois Tool Works
ITW
$85.3B
$65.9M 0.36%
323,297
-5,112
-2% -$1.04M
LH icon
77
Labcorp
LH
$25.6B
$65.6M 0.36%
375,126
-3,473
-0.9% -$600K
BLK icon
78
Blackrock
BLK
$171B
$65.2M 0.36%
90,404
+805
+0.9% +$534K
BRK.B icon
79
Berkshire Hathaway Class B
BRK.B
$1.1T
$63.3M 0.35%
272,799
-3,597
-1% -$792K
MNST icon
80
Monster Beverage
MNST
$95.3B
$62.8M 0.35%
1,359,190
-355,970
-21% -$15M
LEN icon
81
Lennar Class A
LEN
$21B
$62.6M 0.34%
848,749
-29,010
-3% -$2.17M
CHD icon
82
Church & Dwight Co
CHD
$23.9B
$62.5M 0.34%
716,531
-219,736
-23% -$19.5M
COR icon
83
Cencora
COR
$62.1B
$62.4M 0.34%
638,167
-60,101
-9% -$6.01M
LRCX icon
84
Lam Research
LRCX
$338B
$62.2M 0.34%
1,316,930
-1,660,050
-56% -$69.8M
ACWX icon
85
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$62.1M 0.34%
1,170,471
-4,523
-0.4% -$224K
EFA icon
86
iShares MSCI EAFE ETF
EFA
$76.8B
$62M 0.34%
850,153
-38,241
-4% -$2.62M
AME icon
87
Ametek
AME
$55.3B
$58.9M 0.32%
486,839
+38,940
+9% +$4.39M
UNP icon
88
Union Pacific
UNP
$177B
$58.6M 0.32%
281,526
-25,376
-8% -$5.07M
AVY icon
89
Avery Dennison
AVY
$12.9B
$58.1M 0.32%
374,686
+96,867
+35% +$14M
IJT icon
90
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.25B
$55.8M 0.31%
488,292
+14,952
+3% +$1.52M
TSCO icon
91
Tractor Supply
TSCO
$16.7B
$55.6M 0.31%
1,977,485
-474,010
-19% -$13.3M
IVV icon
92
iShares Core S&P 500 ETF
IVV
$871B
$53.8M 0.3%
143,336
-4,092
-3% -$1.46M
EXPD icon
93
Expeditors International
EXPD
$22.4B
$53.6M 0.29%
563,185
-93,646
-14% -$8.53M
USMV icon
94
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$53.4M 0.29%
786,076
-82,636
-10% -$5.44M
ADBE icon
95
Adobe
ADBE
$100B
$53.1M 0.29%
106,265
+42,858
+68% +$20.7M
QCOM icon
96
Qualcomm
QCOM
$171B
$52.9M 0.29%
346,965
-46,358
-12% -$6.46M
REGN icon
97
Regeneron Pharmaceuticals
REGN
$72.3B
$51.7M 0.28%
106,982
-2,191
-2% -$1.18M
ABBV icon
98
AbbVie
ABBV
$469B
$51.7M 0.28%
482,071
-28,471
-6% -$2.74M
TJX icon
99
TJX Companies
TJX
$177B
$50.7M 0.28%
743,101
+21,225
+3% +$1.29M
DBX icon
100
Dropbox
DBX
$7.47B
$50.4M 0.28%
2,271,683
-27,939
-1% -$569K

Similar funds

Glenmede Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Glenmede Trust held 2,614 positions worth $18.2B, up 9% from $16.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $841M in Q4 2020, closing 1,419 positions and reducing 567 holdings. Its most notable exit was H&R Block, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in CryoPort worth $974K.

  • Glenmede Trust's largest Q4 2020 buy was CryoPort: 22,210 shares worth $974K.
  • Glenmede Trust added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $38.7M increase.
  • Glenmede Trust's biggest Q4 2020 reduction was Progressive, cutting an estimated $87.4M.
  • Glenmede Trust fully exited H&R Block in Q4 2020, selling an estimated $18.3M.
  • Glenmede Trust's ten largest holdings make up 19% of its $18.2B portfolio in Q4 2020.
  • Glenmede Trust opened 37 new positions and closed 1,419 in Q4 2020.
  • Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $18.2B.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.